Tag: MassGeneral Institute for Neurodegenerative Disease
-
Nation & World
Nutritional supplement slows onset of Huntington’s
The first clinical trial of a drug intended to delay the onset of symptoms of Huntington’s disease (HD) reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants. Neuroimaging also showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic…
-
Nation & World
Slowing neurodegeneration in Huntington’s
Harvard researchers have found a treatment that increases brain levels of an important regulatory enzyme may slow the loss of brain cells that characterizes Huntington’s disease and other neurodegenerative disorders.
-
Nation & World
Biomarker for Huntington’s identified
In a new research paper published in the Proceedings of the National Academy of Sciences Early Edition online, Harvard-affiliated researchers identify a transcriptional biomarker that may assist in the monitoring of Huntington’s disease activity and in the evaluation of new medications.